Indian Journal of Ophthalmology (Jan 2023)

Response to commentary on: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's ranibizumab with Lucentis in patients with neovascular age-related macular degeneration

  • Chirag Shah,
  • Kishore Sonkusare

DOI
https://doi.org/10.4103/IJO.IJO_2609_22
Journal volume & issue
Vol. 71, no. 3
pp. 1054 – 1055

Abstract

Read online

No abstracts available.